Certara, Inc. (NASDAQ: CERT) is a Healthcare company (Medical - Healthcare Information Services) with a market capitalization of $1.7B. The Maz Rating grades it against the other companies in its sector.
Certara, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $11.06, Certara, Inc. trades at 4.3x sales and 1.7x book value, with an EV/EBITDA of 18.0. Over the last twelve months it generated about $396M of revenue and a net loss of $63M. It runs a gross margin of 59.4%, an operating margin of 1.7% and a net margin of -16.1%. It shows return on equity of -6.4%, return on invested capital of 0.5% and a free cash flow yield of 3.5%. On the balance sheet: a debt-to-equity ratio of 0.30 and a current ratio of 2.58. Over the past 52 weeks the share price ranged from $4.45 to $12.61, with a beta of 1.30.
Certara, Inc. does not currently pay a dividend.
17 Wall Street analyst ratings cover the stock: 8 Buy and 9 Hold, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.